文献速递临床试验与 GCP流行病学与生物统计

院外心脏骤停后治疗性低温的持续时间:ICECAP随机临床试验

Duration of Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: The ICECAP Randomized Clinical Trial.
PubMed 文献 · JAMA · 2026-08-05

该多中心随机适应性分配试验在美国71家医院纳入1158例院外心脏骤停后昏迷幸存者,在33°C低温下随机分配6至72小时不同降温时长。结果显示延长降温时间并未改善90天神经功能,6小时即为与最佳结局一致的最短时长。

要点

  • 延长33°C低温持续时间未改善院外心脏骤停昏迷幸存者的神经功能结局。
  • 不可电击心律队列中6小时为达到最大平均加权mRS评分的最短时长(后验概率0.51)。
  • 可电击心律队列结果与不可电击心律队列相似,各降温时长间死亡率无差异。

核心结论

  • 在33°C治疗性低温治疗的院外心脏骤停昏迷幸存者中,延长降温持续时间未改善神经功能结局。

研究设计与样本

  • 多中心、随机、适应性分配临床试验,在美国71家医院开展,2020年6月至2025年6月入组。
  • 共随机1158例患者,其中不可电击心律883例、可电击心律275例;中位年龄61岁(IQR 50-70),女性占39.6%。
  • 前200例按1:1:1随机分配至12、24、48小时;此后采用反应适应性随机算法优先分配至最可能最优的组别。
  • 主要结局为90天神经功能,采用加权改良Rankin量表评分,以贝叶斯时长-反应模型分析。

主要发现

  • 不可电击心律队列中,6小时为达到最大平均加权mRS评分的最短时长,后验概率为0.51。
  • 可电击心律队列结果与不可电击心律队列相似。
  • 各降温时长间次要结局或死亡率均未观察到差异。
  • 试验在中期分析时达到预设停止规则。

关键数值与推荐

  • 纳入标准:院外心脏骤停后仍昏迷、心脏骤停4小时内达到低于34°C的目标温度、已启动确定性控温装置。
  • 低温方案:33°C治疗性低温,适应性随机分配至6、12、18、24、30、36、42、48、60、72小时。
  • 主要分析方法:贝叶斯时长-反应模型,估计各时长为最优的后验概率;最优指与任何时长下最佳结局一致的最短时长。

临床怎么用

  • 对于院外心脏骤停后昏迷幸存者,33°C低温治疗无需延长降温时间以追求神经功能获益。
  • 6小时可作为与最佳结局一致的最短低温持续时间参考。
  • 临床决策可结合心律类型参考本试验的时长-反应结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Therapeutic hypothermia is widely used for neuroprotection following cardiac arrest, but clinical trials have not consistently demonstrated improved neurological outcomes, and the optimal duration of cooling remains uncertain. OBJECTIVE: To determine the duration of therapeutic hypothermia that maximizes neurological recovery in comatose survivors of out-of-hospital cardiac arrest. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized, adaptive-allocation clinical trial conducted at 71 hospitals in the US. Adults with out-of-hospital cardiac arrest who remained unconscious, achieved a target temperature less than 34 °C within 4 hours of cardiac arrest, and had a definitive temperature control device started were eligible. Patients were enrolled between June 2020 and June 2025. INTERVENTIONS: Therapeutic hypothermia at 33 °C with adaptive randomized allocation to cooling durations of 6, 12, 18, 24, 30, 36, 42, 48, 60, and 72 hours. The first 200 patients were randomized to 12-, 24-, and 48-hour durations in a 1:1:1 ratio. Subsequently, a response-adaptive randomization algorithm allocated preferentially to the groups most likely to be optimal and to best inform the duration-response curve separately within each rhythm type. MAIN OUTCOMES AND MEASURES: The primary outcome was neurological function at 90 days, measured using a weighted modified Rankin Scale score, analyzed using a bayesian duration-response model. The primary analysis estimated the posterior probability that each duration was optimal, wherein optimal indicates the shortest duration consistent with the best outcome observed at any duration. RESULTS: A total of 1158 patients were randomized (883 with nonshockable rhythms and 275 with shockable rhythms). Participants had a median age of 61 (IQR, 50-70) years and 39.6% were female. The trial met a prespecified stopping rule at the interim analysis. For the nonshockable rhythm cohort, the posterior probability that 6 hours was the shortest duration achieving the maximal mean weighted modified Rankin Scale score was 0.51. Results were similar in the shockable rhythm cohort. No differences were observed in secondary outcomes or mortality across cooling durations. CONCLUSIONS AND RELEVANCE: Among comatose survivors of out-of-hospital cardiac arrest treated with therapeutic hypothermia at 33 °C, increasing cooling duration did not improve neurological outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04217551.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Meurer WJ, Yeatts SD, Geocadin RG, et al. Duration of Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: The ICECAP Randomized Clinical Trial. JAMA. 2026. PMID: 42554995. doi:10.1001/jama.2026.10247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。